You are here
Ionising radiation
Soft tissue sarcoma - Ionising radiation Factor
Last reviewed for CCPS 20 August 2008.
Investigative Documents
Claimant Report - Exposure to Ionising Radiation from Alpha Particles [CR9264] Preliminary questions [36212]
36218 the veteran has received ionising radiation from internal deposition of a substance which emits alpha particles at some time. the veteran has received ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at some time. 36214 — the veteran has established the causal connection between ionising radiation and VEA service for the clinical onset of soft tissue sarcoma. 36215 — the veteran has established the causal connection between ionising radiation and operational service for the clinical onset of soft tissue sarcoma. or 36216 — the veteran has established the causal connection between ionising radiation and eligible service for the clinical onset of soft tissue sarcoma. Clinical onset and operational service [36215] or
36227 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles. as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration. 36229 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles, is causally related to operational service. Clinical onset and eligible service [36216] or
36228 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles. as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration.
36230 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by soft tissue sarcoma from internal deposition of a substance which emits alpha particles, is causally related to eligible service.